jueves, 3 de octubre de 2019

NIAID Funding News, October 3, 2019

NIAID Logo

 NIAID Funding News

Feature Articles 

Synopsis of September 2019 Advisory Council Meeting

Dr. Anthony Fauci offered updates on the fiscal year 2020 budget, legislation, and scientific findings for key diseases of interest.

Opportunities and Resources

If you are interested in developing sustained/extended release HIV prevention strategies, this funding opportunity announcement may be of interest to you.
NIAID is interested in myeloid-derived suppressor cells as a therapeutic target for Mycobacterium tuberculosis. Such research should help us better understand the role of host-induced immunosuppression in the progression of tuberculosis.
The StARRTS K38 program is designed to retain and support clinician-investigators from the R38 program, providing K38 award recipients with opportunities for additional research and career development during their subsequent clinical fellowship.

In The News

We are pushing the due date back for NIAID New Innovators Awards applications to November 4, 2019. You still have one month to apply!
Join NIH scientific review officers, program officers, and grants management specialists at the 2019 NIH Regional Seminar on Program Funding and Grants Administration in Phoenix, Arizona, from November 6 to 8, 2019.
For those investigators whose institutions closed due to a natural disaster, NIH will consider accepting applications late. The lateness of your application should not exceed the number of days the applicant institution was officially closed.

Advice Corner

Save yourself time and effort by knowing in what instances you should contact a grants management specialist instead of a program officer.

Reader Questions

New Funding Opportunities

See other announcements at Opportunities & Announcements.
Send suggestions or comments to deaweb@niaid.nih.gov.

No hay comentarios: